A study in Molecules uncovers "significant labeling discrepancies" between the labeled cannabinoid content and the actual composition of cannabis-based products sold in Portugal.
The findings underscore a potential problem for the packaging industry, as inaccurate labeling can lead to consumer safety concerns and legal issues. The study looked at different products acquired from pharmacies and street shops, namely beverages, herbal samples, oils and cosmetic products.
The research, which investigated products from pharmacies and street vendors, underscores the importance of reliable packaging solutions for cannabis products. With increasing legalization and market growth, ensuring accurate labeling becomes paramount.
"Among sampled beverages, none contained detectable cannabinoids, despite suggestive packaging. Similarly, oils often differed from the declared cannabinoid compositions, with some containing significantly higher CBD concentrations than labeled," write the researchers.
"These inconsistencies raise serious concerns regarding consumer safety and informed decision-making. Moreover, our findings underscore the need for stringent regulation and standardized testing protocols to ensure the accuracy and safety of cannabis-based products."
Read more at nutritioninsight.com